Lord, Abbett & Co’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-150,577
Closed -$4.43M 654
2019
Q4
$4.43M Sell
150,577
-21
-0% -$571 0.01% 607
2019
Q3
$4M Sell
150,598
-450,000
-75% -$13.5M 0.01% 645
2019
Q2
$20.3M Buy
600,598
+457,472
+320% +$14.9M 0.07% 417
2019
Q1
$4.59M Sell
143,126
-512,935
-78% -$15.8M 0.02% 656
2018
Q4
$20.7M Buy
656,061
+541,648
+473% +$17.7M 0.08% 377
2018
Q3
$3.99M Buy
+114,413
New +$4.02M 0.01% 761

Other funds holding ELAN

Lord, Abbett & Co's ELAN Position: Q1 2020 in Review

Lord, Abbett & Co sold out of Elanco Animal Health (ELAN) in Q1 2020, closing a stake of 150,577 shares — an estimated $4.43M sold.

Lord, Abbett & Co first reported a position in ELAN in Q3 2018 and held it in 6 quarters. The position peaked at $20.7M in Q4 2018. 371 funds tracked by Wall St. Rank hold ELAN as of Q1 2020.

  • Lord, Abbett & Co reported no remaining Elanco Animal Health position as of Q1 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 150,577 Elanco Animal Health shares in Q1 2020, an estimated $4.43M.
  • Lord, Abbett & Co first reported a position in Elanco Animal Health in Q3 2018 and held it in 6 quarters.
  • Lord, Abbett & Co's Elanco Animal Health position peaked at $20.7M in Q4 2018.
  • 371 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2020.

Based on Lord, Abbett & Co's 13F filing for Q1 2020, filed 14 May 2020.